These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent. Coward DM; Doggett NS; Sayers AC Arzneimittelforschung; 1977; 27(12):2326-32. PubMed ID: 580044 [TBL] [Abstract][Full Text] [Related]
7. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum. Dismukes K; Mulder AH Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics. Nakajima T; Egawa E; Kuruma I Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446 [TBL] [Abstract][Full Text] [Related]
9. The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954. Coward DM; Doggett NS Psychopharmacology (Berl); 1977 Apr; 52(2):165-71. PubMed ID: 407600 [TBL] [Abstract][Full Text] [Related]
10. Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat. Oakley NR; Hayes AG; Sheehan MJ Psychopharmacology (Berl); 1991; 105(2):204-8. PubMed ID: 1686655 [TBL] [Abstract][Full Text] [Related]
11. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity. Goosey MW; Doggett NS Biochem Pharmacol; 1983 Aug; 32(16):2411-6. PubMed ID: 6137221 [TBL] [Abstract][Full Text] [Related]
13. Central transmitter involvement in LON-954-induced tremorogenesis. Coward DM; Doggett NS; Thomas JE Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244 [No Abstract] [Full Text] [Related]
14. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297 [TBL] [Abstract][Full Text] [Related]
15. Muscarinic m4 receptor activation by some atypical antipsychotic drugs. Zeng XP; Le F; Richelson E Eur J Pharmacol; 1997 Mar; 321(3):349-54. PubMed ID: 9085047 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Walters JR; Roth RH Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315 [TBL] [Abstract][Full Text] [Related]
17. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Stamford JA; Kruk ZL; Millar J Br J Pharmacol; 1988 Jul; 94(3):924-32. PubMed ID: 2902896 [TBL] [Abstract][Full Text] [Related]
18. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Ward RP; Dorsa DM Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625 [TBL] [Abstract][Full Text] [Related]
19. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. Parsons B; Togasaki DM; Kassir S; Przedborski S J Neurochem; 1995 Nov; 65(5):2057-64. PubMed ID: 7595490 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Costall B; Naylor RJ Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]